Clinical Trial Update: Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck [Phase 1]

View source ↗

Summary

Phase 1 study evaluating gefitinib and paclitaxel with radiation therapy in advanced or recurrent squamous cell carcinoma of the head and neck. The trial has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Iressa (gefitinib)
• Taxol (paclitaxel)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED